Thyroid Dysfunction and Fibrin Network Structure: A Mechanism for Increased Thrombotic Risk in Hyperthyroid Individuals

Molecular Intercommunication between the Complement and Coagulation Systems

Amara, U., Flierl, M. A., Rittirsch, D., Klos, A., Chen, H., Acker, B., Brückner, U. B., Nilsson, B., Gebhard, F. T., Lambris, J. D., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903678 · Cited by 719 · see citing works

Inflammation and atherosclerosis: role of C-Reactive protein in risk assessment

Libby, P., & Ridker, P. M. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.02.006 · Cited by 596 · see citing works

Influence of Fibrin Network Conformation and Fibrin Fiber Diameter on Fibrinolysis Speed

Collet, J. ‐., Park, D., Lesty, C., Soria, J., Soria, C., Montalescot, G., & Weisel, J. W. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.5.1354 · Cited by 492 · see citing works

Altered Fibrin Architecture Is Associated With Hypofibrinolysis and Premature Coronary Atherothrombosis

Jp, C., Allali, Y., Lesty, C., Tanguy, M., Silvain, J., Ankri, A., Blanchet, B., Dumaine, R. L., Gianetti, J., Payot, L., et al. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000241589.52950.4c · Cited by 348 · see citing works

Autoimmune thyroid disease: propagation and progression

Weetman, A. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1480001 · Cited by 223 · see citing works

Thyroid Dysfunction and Effects on Coagulation and Fibrinolysis: A Systematic Review

Squizzato, A., Romualdi, E., Buller, H. R., & Gerdes, V. E. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0199 · Cited by 222 · see citing works

Proneness to Formation of Tight and Rigid Fibrin Gel Structures in Men with Myocardial Infarction at a Young Age

Fatah, K., Silveira, A. M. V., Tornvall, P., Karpe, F., Blombäck, M., & Hamsten, A. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650618 · Cited by 221 · see citing works

Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: Effects of inflammation and oxidative stress

Undas, A., Szuldrzynski, K. S., Stępień, E. Ł., Zalewski, J., Godlewski, J., Tracz, W., Pasowicz, M., & Zmudka, K. F. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.028 · Cited by 191 · see citing works

Altered Fibrin Clot Structure in the Healthy Relatives of Patients With Premature Coronary Artery Disease

Mills, J. D., Ariëns, R. A. S., Mansfield, M. W., et al. (2002) · Circulation · doi:10.1161/01.cir.0000033221.73082.06 · Cited by 186 · see citing works

Heritability of Clot Formation, Morphology, and Lysis

Carter, A. M., Cymbalista, C. M., Spector, T. D., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.153221 · Cited by 180 · see citing works

Blood coagulation and fibrinolysis in patients with hyperthyroidism

Erem, C., Ersöz, H. Ö., Karti, S. S., Ükinç, K., Hacıhasanoğlu, A., Değer, O., & Telatar, M. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03344016 · Cited by 142 · see citing works

Arterial Embolism in Thyrotoxicosis With Atrial Fibrillation

Bar-Sela, S. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340090087019 · Cited by 138 · see citing works

Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity

Erem, C. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02464.x · Cited by 136 · see citing works

Altered Fibrin Clot Structure/Function in Patients With Cryptogenic Ischemic Stroke

Undas, A., Podolec, P. S., Zawilska, K., Pieculewicz, M., Jedliński, I. M., Stępień, E. Ł., Konarska-Kuszewska, E., Węglarz, P., Duszyńska, M., Hanschke, E., et al. (2009) · Stroke · doi:10.1161/strokeaha.108.532812 · Cited by 133 · see citing works

Local complement activation triggers neutrophil recruitment to the site of thrombus formation in acute myocardial infarction

Distelmaier, K., Adlbrecht, C., Jakowitsch, J., Winkler, S., Dunkler, D., Gerner, C., Wagner, O. F., Lang, I. M., & Kubicek, M. (2009) · Thrombosis and Haemostasis · doi:10.1160/th09-02-0103 · Cited by 120 · see citing works

Endothelial Function in Patients with Hyperthyroidism Before and After Treatment with Propranolol and Thiamazol

Burggraaf, J., Lalezari, S., EMEIS, J. J., Vischer, U. M., Meyer, P., Pijl, H., & Cohen, A. F. (2001) · Thyroid · doi:10.1089/105072501300042820 · Cited by 108 · see citing works

A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3

Hess, K., ALZAHRANI, S. H., Mathai, M., Schroeder, V., Carter, A. M., Howell, G. J., Koko, T., Strachan, M. W. J., Price, J. F., Smith, K. A., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2301-7 · Cited by 104 · see citing works

Thyrotoxicosis, atrial fibrillation, and embolism, revisited

Presti, C. F., & Hart, R. G. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90642-x · Cited by 103 · see citing works

Factor VIII Activity and Thyroid Function

Rogers, J., SHANE, S. R., & JENCKS, F. S. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-5-713 · Cited by 103 · see citing works

Coagulation disorders in thyroid diseases

Hofbauer, L. C., & Heufelder, A. E. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1360001 · Cited by 95 · see citing works

Complement-endothelial cell interactions: pathophysiological implications

Tedesco, F. (1999) · Molecular Immunology · doi:10.1016/s0161-5890(99)90054-8 · Cited by 84 · see citing works

Common variation in the C-terminal region of the fibrinogen β-chain: effects on fibrin structure, fibrinolysis and clot rigidity

Ajjan, R., Lim, B. C. B., Standeven, K. F., et al. (2007) · Blood · doi:10.1182/blood-2007-05-091231 · Cited by 79 · see citing works

Altered fibrin clot properties in patients on long-term haemodialysis: relation to cardiovascular mortality

Undas, A., Kolarz, M., Kopeć, G., et al. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm884 · Cited by 76 · see citing works

Low serum thyrotropin is associated with high plasma fibrinogen

Dörr, M., Robinson, D. M., Wallaschofski, H., Schwahn, C., John, U., Felix, S. B., & Völzke, H. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1786 · Cited by 73 · see citing works

Hyperthyroidism and venous thrombosis: a casual or causal association? A systematic literature review

Franchini, M., Lippi, G., & Targher, G. (2011) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029610364521 · Cited by 71 · see citing works

Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects

Yu, H., Yang, Y., Zhang, M., Lü, H., Zhang, J., Wang, H., & Cianflone, K. (2006) · Nutrition & Metabolism · doi:10.1186/1743-7075-3-13 · Cited by 66 · see citing works

Complement C3 and C-reactive protein levels in patients with stable coronary artery disease

Ajjan, R., Futers, T. S., Brown, J., Cymbalista, C. M., Boothby, M., Carter, A., & Grant, P. J. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-06-0384 · Cited by 65 · see citing works

Thyroid Dysfunction and Hemostasis: An Issue Still Unresolved

Franchini, M., Montagnana, M., Manzato, F., & Vescovi, P. P. (2009) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0029-1222607 · Cited by 64 · see citing works

Hormonal regulation of mannan-binding lectin synthesis in hepatocytes

Sørensen, C. M., Hansen, T. K., Steffensen, R., Jensenius, J. C., & Thiel, S. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03101.x · Cited by 63 · see citing works

Immunological and hematological changes in patients with hyperthyroidism or hypothyroidism

Jafarzadeh, A., Poorgholami, M., Izadi, N., et al. (2010) · Clinical and investigative medicine · doi:10.25011/cim.v33i5.14352 · Cited by 61 · see citing works

The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients.

Skellern, G., Knight, B., Low, C., et al. (1980) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1980.tb05823.x · Cited by 60 · see citing works

Venous Thromboembolism in Patients Hospitalized With Thyroid Dysfunction

Danescu, L. G., Badshah, A., Danescu, S. C., Janjua, M. S. T., Marandici, A. M., Matta, F., Yaekoub, A. Y., Malloy, D. J., & Stein, P. D. (2009) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029609336856 · Cited by 52 · see citing works

Alterations in coagulation and fibrinolysis after levothyroxine exposure in healthy volunteers: a controlled randomized crossover study

VAN ZAANE, B., SQUIZZATO, A., DEBEIJ, J., DEKKERS, O. M., MEIJERS, J. C. M., VAN ZANTEN, A. P., BÜLLER, H. R., GERDES, V. E. A., CANNEGIETER, S. C., & BRANDJES, D. P. M. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04430.x · Cited by 46 · see citing works

Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment

Marongiu, F., Conti, M. V., Mameli, G., et al. (1988) · Journal of Endocrinological Investigation · doi:10.1007/bf03350928 · Cited by 34 · see citing works

The Spectrum of Coagulation Abnormalities in Thyroid Disorders

Vescovi, P. P., Favaloro, E. J., Lippi, G., et al. (2011) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0030-1270065 · Cited by 31 · see citing works

Activation of Blood Coagulation and Fibrinolysis in Graves' Disease

Marongiu, F., Conti, M., Murtas, M. L., et al. (1991) · Hormone and Metabolic Research · doi:10.1055/s-2007-1003766 · Cited by 28 · see citing works

Thionamides Inhibit the Transcription Factor Nuclear Factor-κB by Suppression of Rac1 and Inhibitor of κB Kinase α

Humar, M., Dohrmann, H., Stein, P., et al. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.132407 · Cited by 25 · see citing works

The production of mannan-binding lectin is dependent upon thyroid hormones regardless of the genotype: A cohort study of 95 patients with autoimmune thyroid disorders

Potluková, E., Jiskra, J., Freiberger, T., Limanova, Z., Zivorova, D., Malíčková, K., Springer, D., Grodecká, L., Antošová, M., Telička, Z., et al. (2010) · Clinical Immunology · doi:10.1016/j.clim.2010.02.015 · Cited by 23 · see citing works

Effects of exogenous thyroxine on C-2 and C-16a hydroxylations of estradiol in humans

Michnovicz, J. J. (1990) · Steroids · doi:10.1016/0039-128x(90)90069-n · Cited by 23 · see citing works

Levels of plasma fibrinogen and D-dimer in subjects with subclinical hyperthyroidism.

Çoban, E., & Aydemir, M. (2008) · PubMed · Cited by 22 · see citing works

Correlation between serum thyroxine and complements in patients with multiple sclerosis and neuromyelitis optica.

Zhang, B., Jiang, Y., Yang, Y., et al. (2008) · PubMed · Cited by 20 · see citing works

Complement activation: a new participant in the modulation of fibrin gel characteristics and the progression of atherosclerosis?

Ea, S.-T., Nair, C. H., & Dp, D. (1994) · PubMed · Cited by 14 · see citing works

The influence of thyroid function on the coagulation system and its clinical consequences

Elbers, L. P. B., Fliers, E., & Cannegieter, S. C. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13970 · Cited by 123 · see citing works

The effects of treatment with liraglutide on atherothrombotic risk in obese young women with polycystic ovary syndrome and controls

Kahal, H., Aburima, A., Ungvari, T., Rigby, A. S., Coady, A. M., Vince, R. V., Ajjan, R. A., Kilpatrick, E. S., Naseem, K. M., & Atkin, S. L. (2015) · BMC Endocrine Disorders · doi:10.1186/s12902-015-0005-6 · Cited by 74 · see citing works

Plasma proteome and metabolome characterization of an experimental human thyrotoxicosis model

Pietzner, M., Engelmann, B., Kacprowski, T., Golchert, J., Dirk, A.-L., Hammer, E., Iwen, K. A., Nauck, M., Wallaschofski, H., Führer, D., et al. (2017) · BMC Medicine · doi:10.1186/s12916-016-0770-8 · Cited by 40 · see citing works

Thyroid function and cardiovascular disease: the mediating role of coagulation factors.

Bano, A., Chaker, L., de Maat, M. P. M., Atiq, F., Kavousi, M., Franco, O. H., Mattace-Raso, F. U. S., Leebeek, F. W. G., & Peeters, R. P. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00072 · Cited by 25 · see citing works

Pharmacodynamic and Therapeutic Actions of Levothyroxine

Hennessey, J. V. (2021) · 70 Years of Levothyroxine · doi:10.1007/978-3-030-63277-9_3 · Cited by 4 · see citing works

Tranexamic acid is associated with increased mortality in patients with physiological fibrinolysis

Moore, H. B., Moore, E. E., Huebner, B. R., et al. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.04.028 · Cited by 110 · see citing works

Enhanced fibrinolysis detection in a natural occurring canine model with intracavitary effusions: Comparison and degree of agreement between thromboelastometry and FDPs, D-dimer and fibrinogen concentrations

Zoia, A., Drigo, M., Piek, C. J., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225089 · Cited by 7 · see citing works

Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown

Moore, H. B., Moore, E. E., González, E., et al. (2014) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000341 · Cited by 451 · see citing works

Relationship Between Severity of Fibrinolysis Based on Rotational Thromboelastometry and Conventional Fibrinolysis Markers

Saito, T., Hayakawa, M., Honma, Y., et al. (2020) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029620933003 · Cited by 7 · see citing works

Rationale for the selective administration of tranexamic acid to inhibit fibrinolysis in the severely injured patient

Moore, E. E., Moore, H. B., González, E., et al. (2016) · Transfusion · doi:10.1111/trf.13486 · Cited by 114 · see citing works